Study to Determine the Excretion and Metabolism of 14C-ETX2514 Administered Intravenously in Healthy Male Subjects
Clinical trial NCT04018950 · COMPLETED
Trial details
- NCT number
- NCT04018950
- Sponsor
- Entasis Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-21
- Primary completion
- 2019-07-26
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.